Amino acid transporter SLC6A14 depends on heat shock protein HSP90 in trafficking to the cell surface.
Adenosine Triphosphatases
/ metabolism
Amino Acid Transport Systems
/ genetics
Biotinylation
Bortezomib
/ pharmacology
Carrier Proteins
/ drug effects
Cell Membrane
/ metabolism
Cytosol
/ metabolism
Endoplasmic Reticulum
/ metabolism
Endoplasmic Reticulum-Associated Degradation
HSP70 Heat-Shock Proteins
/ antagonists & inhibitors
HSP90 Heat-Shock Proteins
/ antagonists & inhibitors
Humans
MCF-7 Cells
Macrolides
/ pharmacology
Molecular Chaperones
/ metabolism
Proteasome Endopeptidase Complex
/ drug effects
Protein Folding
Protein Transport
/ drug effects
Purine Nucleosides
/ pharmacology
ATB(0,+)
HSP90
Heat shock protein
SLC6A14
Journal
Biochimica et biophysica acta. Molecular cell research
ISSN: 1879-2596
Titre abrégé: Biochim Biophys Acta Mol Cell Res
Pays: Netherlands
ID NLM: 101731731
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
27
03
2019
revised:
21
06
2019
accepted:
16
07
2019
pubmed:
22
7
2019
medline:
17
1
2020
entrez:
22
7
2019
Statut:
ppublish
Résumé
Plasma membrane transporter SLC6A14 transports all neutral and basic amino acids in a Na/Cl - dependent way and it is up-regulated in many types of cancer. Mass spectrometry analysis of overexpressed SLC6A14-associated proteins identified, among others, the presence of cytosolic heat shock proteins (HSPs) and co-chaperones. We detected co-localization of overexpressed and native SLC6A14 with HSP90-beta and HSP70 (HSPA14). Proximity ligation assay confirmed a direct interaction of overexpressed SLC6A14 with both HSPs. Treatment with radicicol and VER155008, specific inhibitors of HSP90 and HSP70, respectively, attenuated these interactions and strongly reduced transporter presence at the cell surface, what resulted from the diminished level of the total transporter protein. Distortion of SLC6A14 proper folding by both HSPs inhibitors directed the transporter towards endoplasmic reticulum-associated degradation pathway, a process reversed by the proteasome inhibitor - bortezomib. As demonstrated in an in vitro ATPase assay of recombinant purified HSP90-beta, the peptides corresponding to C-terminal amino acid sequence following the last transmembrane domain of SLC6A14 affected the HSP90-beta activity. These results indicate that a plasma membrane protein folding can be controlled not only by chaperones in the endoplasmic reticulum, but also those localized in the cytosol.
Identifiants
pubmed: 31326539
pii: S0167-4889(19)30124-7
doi: 10.1016/j.bbamcr.2019.07.009
pii:
doi:
Substances chimiques
Amino Acid Transport Systems
0
Carrier Proteins
0
HSP70 Heat-Shock Proteins
0
HSP90 Heat-Shock Proteins
0
Hspa14 protein, human
0
Macrolides
0
Molecular Chaperones
0
Purine Nucleosides
0
SLC6A14 protein, human
0
VER 155008
0
Bortezomib
69G8BD63PP
Proteasome Endopeptidase Complex
EC 3.4.25.1
Adenosine Triphosphatases
EC 3.6.1.-
monorden
I60EH8GECX
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1544-1555Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.